N

Netmed Inc
OTC:NTME

Watchlist Manager
Netmed Inc
OTC:NTME
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $548.5k

Netmed Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Netmed Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
N
Netmed Inc
OTC:NTME
Free Cash Flow
-$289k
CAGR 3-Years
33%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Free Cash Flow
$3.7B
CAGR 3-Years
57%
CAGR 5-Years
30%
CAGR 10-Years
35%
Edwards Lifesciences Corp
NYSE:EW
Free Cash Flow
$1.3B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Free Cash Flow
$4.3B
CAGR 3-Years
28%
CAGR 5-Years
9%
CAGR 10-Years
20%
Abbott Laboratories
NYSE:ABT
Free Cash Flow
$7.4B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
15%
Intuitive Surgical Inc
NASDAQ:ISRG
Free Cash Flow
$2.5B
CAGR 3-Years
37%
CAGR 5-Years
17%
CAGR 10-Years
13%
No Stocks Found

Netmed Inc
Glance View

Market Cap
548.5k USD
Industry
Health Care

NetMed, Inc. engages in the research and development of proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. The company is headquartered in Dublin Ohio, Ohio and currently employs 1 full-time employees. During the fiscal year ended December 31, 2001, the Company's sole business activity, through its majority-owned subsidiary, OxyNet, Inc., involved research and development activities associated with a proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. These activities were suspended effective December 31, 2001, pending efforts to locate a prospective licensee or development partner. The firm is continuing efforts, begun in 2001, to evaluate other business opportunities, which included preliminary investigation and due diligence. These efforts have not, in the judgment of the Company's management, produced an attractive merger or acquisition candidate. The firm is seeking a candidate with a proprietary product or service, which may be in the development stage, and offers an opportunity to realize these objectives.

NTME Intrinsic Value
Not Available
N

See Also

What is Netmed Inc's Free Cash Flow?
Free Cash Flow
-289k USD

Based on the financial report for Jun 30, 2002, Netmed Inc's Free Cash Flow amounts to -289k USD.

What is Netmed Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
29%

Over the last year, the Free Cash Flow growth was 33%. The average annual Free Cash Flow growth rates for Netmed Inc have been 33% over the past three years , 29% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett